Back
AbCellera Biologics, Inc. 10K Form
Sell
31
ABCL
AbCellera Biologics, Inc.
Last Price:
$3.56
Seasonality Move:
-22.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-30 | 10K | ABCL/AbCellera Biologics, Inc. Annual |
Receive ABCL News And Ratings
See the #1 stock for the next 7 days that we like better than ABCL
ABCL Financial Statistics
Sales & Book Value
| Annual Sales: | $28.8M |
|---|---|
| Cash Flow: | $-62.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.22 |
| Price / Book: | 1.11 |
Profitability
| EPS (TTM): | -0.57630 |
|---|---|
| Net Income (TTM): | $-171.7M |
| Gross Margin: | $-68.2M |
| Return on Equity: | -16.74% |
| Return on Assets: | -12.52% |
AbCellera Biologics, Inc. Earnings Forecast
Key AbCellera Biologics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for ABCL is -236.42%.
-
The Selling, General & Administrative Expenses for ABCL have been equal to 296.50% of Gross Profit Margin.
-
The Research & Development expenses have been 580.10% of Revenue.
-
The Net Earning history of ABCL is -564.83% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
AbCellera Biologics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | ABCL |
| CUSIP: | 00288U |
| Website: | abcellera.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 10.1 |
| Quick Ratio: | 8.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.42 |
|---|---|
| Forward P/E Ratio: | 0 |
ABCL Technical Analysis vs Fundamental Analysis
Sell
31
AbCellera Biologics, Inc. (ABCL)
is a Sell
Is AbCellera Biologics, Inc. a Buy or a Sell?
-
AbCellera Biologics, Inc. stock is rated a SellThe current AbCellera Biologics, Inc. [ABCL] share price is $3.56. The Score for ABCL is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.